Our research program is devoted to the analysis of events governing the progression and maintenance of
cancer. In this respect, our research is specifically oriented in understanding of molecular mechanisms
governing cancer chemo-resistance and progression. We are also focused on identifying novel anti-cancer
compounds and analysis of their mechanism of action. Our spectrum of research interest includes the
- Role of autophagy and associated signaling in cancer chemo-resistance.
- Role of non-coding RNAs in cancer chemo-resistance.
- Evaluating anti-cancer properties of camel milk and studying its mechanism of action.
- Experimental approaches to validate mathematical models on cancer and immune cell interaction kinetics in presence or absence of potent anti-cancer drugs and immunopotentiating agents.
- Role of pro-inflammatory cytokines in cancer progression, especially in epithelial to mesenchymal transition (EMT).